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Introduction 
     Marijuana is used in the United States 
and worldwide.1 It sometimes is used by 
patients, most generally illegally, for its 
antiemetic properties. Paradoxically, it 
actually can cause nausea and vomiting with 
abdominal pain in some patients. In recent 
years, there has been recognition of a new 
clinical condition known as Cannabinoid 
Hyperemesis Syndrome (CHS). This 
syndrome was first described in 2004 and is 
characterized by chronic cannabis use, 
cyclic episodes of nausea and vomiting, and 
the learned behavior of hot bathing or 
showering.2 In some cases, polydipsia is 
present. We present the case of a young man 
who came to our emergency department 
with classic symptoms and history of this 
diagnosis of exclusion. 
 
Case Report 
     A 22-year-old male with a past medical 
history of Gilbert syndrome presented to an 
academic medical center with a complaint of 
constant, sharp, diffuse abdominal pain, as 
well as nausea and vomiting of four days 
duration. The patient ranked his pain as 
10/10 without relief. He had not eaten for 
several days as this worsened his symptoms. 
He denied fever, chills, diarrhea or bleeding. 
His jaundice was consistent with baseline 
due to Gilbert syndrome. He previously was 
hospitalized at a local hospital one month 
prior due to similar symptoms and later 
admitted that he had been hospitalized at 
several other local hospitals in the past with 
similar complaints, but generally had left 
against medical advice because they “did not 
let me shower enough”. He admitted to 
heavy, daily marijuana use of 3-5 cigarettes 
(“joints”) for the past three years. At times, 
he booked a hotel room for hot baths and 
showers during these pain episodes, which 
occurred every 1-2 months and lasted 4-5 
days.  His first episode occurred one year 
after his marijuana use increased 
significantly. 
     His urinary drug screen was positive for 
tetrahydrocannabinol (THC), but no other 
illicit substances. He was admitted to the 
hospital due to uncontrolled pain. In the 
emergency department, he requested a hot 
shower several times. At admission, he was 
asked to remain without food and drink for 
possible testing. Despite this request, he was 
observed drinking out of the sink in the 
radiology suite and getting out of the 
transport wheelchair to drink from a water 
fountain while returning to his room. During 
hospitalization, he was frequently in the 
shower, up to eight times a day, and was 
frequently unavailable to health care 
professionals. 
A complete blood count, comprehensive 
metabolic profile, and lipase were within 
normal limits except for the elevated 
bilirubin which was consistent with his 
diagnosis of Gilbert Syndrome. An 
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abdominal ultrasound did not reveal 
cholelithiasis or ductal dilatation. A recent 
computed tomography scan of the 
abdomen/pelvis from an outside hospital 
was unremarkable and did not reveal a 
source for his pain. 
An esophagogastroduodenoscopy 
revealed mid to distal esophagitis and he 
was started on a twice daily proton pump 
inhibitor.  At the time of discharge, his 
abdominal pain, nausea, and vomiting were 
improved and the frequency of showering 
had decreased.  No evidence of celiac 
disease or H. pylori was found.  It was not 
thought that the esophagitis was the source 
of his symptoms as there is no known 
relationship between it and excessive 
showering. A gastric emptying study was 
not obtained during hospitalization due to 
narcotic use to control the pain and was 
scheduled to be done as an out-patient. A 
psychiatry consult was not obtained. 
The patient was advised to quit 
marijuana usage and have a follow-up 
appointment with the consulting 
gastroenterologist for the gastric emptying 
study.  A copy of a Canadian article on 
cannabinoid hyperemesis syndrome was 
given to the patient.3 Unfortunately, he 
missed the gastroenterology appointment 
and gastric emptying study and was lost to 
follow-up. Approximately a year later, he 
presented to the ED with similar complaints 
and his family indicated he was smoking 
marijuana heavily again. He recently had 
been hospitalized twice at outside hospitals 
for similar presentations. According to his 
family, during his periods of marijuana 
abstinence, his nausea, vomiting and 
abdominal pain resolved.  
 
Discussion 
     Cannabinoid hyperemesis syndrome 
(CHS) is characterized by cyclic episodes of 
abdominal pain, nausea, vomiting, and 
compulsive hot bathing or showering, with 
some descriptions include polydipsia.2 
Soriano-Co et al.,4 building on the previous 
work of Sontineni et al,5 suggested major 
and supporting features supporting the 
diagnosis. The major features included: (1) 
severe cyclic nausea and vomiting, (2) 
resolution with cannabis cessation, (3) relief 
of symptoms with hot showers or baths, (4) 
abdominal pain, and (5) weekly use of 
cannabis. Supportive features included: (1) 
age younger than 50 years, (2) weight loss 
of greater than 5 kg, (3) morning 
predominance of symptoms, (4) normal 
bowel habits, and (5) negative findings on 
diagnostic evaluation. The syndrome 
consists of three phases: pre-emetic or 
prodromal, hyperemetic, and recovery 
phase. The pre-emetic prodromal phase lasts 
for months or years and is characterized by 
early morning nausea, a fear of vomiting, 
and abdominal discomfort. The hyperemetic 
phase is characterized by complaints of 
intense and persistent nausea, vomiting and 
pain. During this phase patients classically 
take numerous hot showers or baths 
throughout the day.  This behavior appears 
to be learned, as it is the only measure 
known to control symptoms, and therefore, 
it quickly becomes a conditioned  behavior.3 
The pathophysiology of CHS is 
unknown. Possible mechanisms of 
cannabinoid hyperemesis include toxicity 
resulting from marijuana's long half-life, its 
lipophilic properties, its ability to delay 
gastric emptying, and its dysregulation of 
thermoregulatory and autonomic 
equilibrium.2 One hypothesis is that heavy 
exposure to THC results in supersaturation 
of cannabinoid receptors which results in a 
decrease in the number of receptors, a 
phenomenon known as desensitization, and 
their gabanergic effects, including nausea 
suppression, is diminished. The association 
between hot showering and symptom relief 
is understood less clearly, but may involve 
the fact that THC increases central body 
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temperature and hot water may result in a 
paradoxical perception of cold when 
cutaneous cold fibers are exposed to a hot 
stimulus. 
Patients frequently have multiple 
hospitalizations and often fail to be 
diagnosed for a considerable time period, 
sometimes being diagnosed with cyclic 
vomiting syndrome (CVS).6-8 Though both 
conditions have similar presentations, 
including cycles of vomiting and sometimes 
abdominal pain, with CVS patients 
frequently have migraine headaches and 
rapid gastric emptying times, whereas CHS 
is associated with delayed gastric emptying. 
The recovery phase requires abstinence 
from marijuana usage to prevent the return 
of symptoms. Patient education is crucial in 
the treatment and ultimate resolution of this 
debilitating syndrome. The efficacy of 
outpatient treatment options, such as 
cognitive behavioral therapy for marijuana 
dependence, should be considered.9 
 
Conclusions 
The purpose of reporting this case of 
cannabinoid hyperemesis syndrome is to 
increase awareness of this likely 
underdiagnosed syndrome, its symptoms, 
including the peculiar need for frequent hot 
bathing, and characteristic phases. In 
patients with severe, intermittent abdominal 
pain who have a history of prolonged, heavy 
cannabis use, this diagnosis should be 
entertained. 
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